Literature DB >> 6320902

Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.

M Gowen, D D Wood, E J Ihrie, J E Meats, R G Russell.   

Abstract

Human articular chondrocytes in culture synthesise collagenase and neutral proteoglycanase in response to addition of a 12-17 kDa protein produced by cultured human monocytes. This factor copurifies with interleukin 1, as assessed by lymphocyte activating factor activity, on gel filtration chromatography and isoelectric focusing. The interleukin 1 and chondrocyte-stimulating activities are destroyed by pretreatment of the material with phenylglyoxal. The same materials also promote the release of glycosaminoglycans from cultures of intact bovine nasal cartilage. The proteoglycanase activity release from chondrocytes appears to be a metalloproteinase because it is inhibited by EDTA and not by phenylmethylsulphonyl fluoride (PMSF), and because detection of its activity is dependent on the presence of 4-aminophenylmercuric acetate. Human osteoblast-like cells do not respond to this factor by increased proteinase production, but are stimulated to produce prostaglandins. These results suggest that interleukin 1 has activities upon non-immune cells which promote the degradation of connective tissue matrices. Human osteoblasts do not synthesise neutral collagen- and proteoglycan-degrading enzymes and thus are unlikely to be directly responsible for the matrix degradation which occurs during bone resorption.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320902     DOI: 10.1016/0304-4165(84)90121-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  56 in total

1.  New cell lines with chondrocytic phenotypes from human chondrosarcoma.

Authors:  Ikuo Kudawara; Nobuhito Araki; Akira Myoui; Yoichi Kato; Atsumasa Uchida; Hideki Yoshikawa
Journal:  Virchows Arch       Date:  2004-04-29       Impact factor: 4.064

2.  Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors.

Authors:  J B Smith; M H Bocchieri; L Sherbin-Allen; M Borofsky; J L Abruzzo
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

Authors:  R H Daniels; B D Williams; B P Morgan
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

4.  Evidence that responses of articular chondrocytes to interleukin-1 and basic fibroblast growth factor are not mediated by protein kinase C.

Authors:  K I Hulkower; H I Georgescu; C H Evans
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

5.  Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes.

Authors:  John-Max Mongkhon; Maryane Thach; Qin Shi; Julio C Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Inflamm Res       Date:  2014-05-25       Impact factor: 4.575

6.  Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy.

Authors:  D Bisbocci; V Gallo; P Damiano; L Sidoli; R Cantoni; G Aimo; G Priolo; R Pagni; L Chiandussi
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

7.  Partial characterization of an interleukin-1-like factor in human gingival crevicular fluid from patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; Y Iwamoto; T Hirofuji; M Yoneda; K Yamashita; M Aono
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 8.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

9.  High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background.

Authors:  M Okamoto; M Takagi; M Kutsuna; Y Hara; M Nishihara; M C Zhang; T Matsuda; M Sakanaka; S Okamoto; M Nose; Y Ohashi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.